GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jolt Health Inc (XCNQ:JOLT) » Definitions » Cyclically Adjusted Price-to-FCF

Jolt Health (XCNQ:JOLT) Cyclically Adjusted Price-to-FCF : (As of Jun. 10, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Jolt Health Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Jolt Health Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Jolt Health's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jolt Health Cyclically Adjusted Price-to-FCF Chart

Jolt Health Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Jolt Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Jolt Health's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Jolt Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jolt Health's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jolt Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Jolt Health's Cyclically Adjusted Price-to-FCF falls into.



Jolt Health Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Jolt Health's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Jolt Health's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.003/126.2576*126.2576
=-0.003

Current CPI (Mar. 2024) = 126.2576.

Jolt Health Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.004 99.473 -0.005
201409 0.017 99.394 0.022
201412 -0.025 98.367 -0.032
201503 -0.067 99.789 -0.085
201506 -0.015 100.500 -0.019
201509 -0.022 100.421 -0.028
201512 -0.004 99.947 -0.005
201603 -0.041 101.054 -0.051
201606 0.063 102.002 0.078
201609 0.032 101.765 0.040
201612 0.007 101.449 0.009
201703 -0.011 102.634 -0.014
201706 -0.025 103.029 -0.031
201709 0.012 103.345 0.015
201712 0.055 103.345 0.067
201803 0.264 105.004 0.317
201806 0.000 105.557 0.000
201809 -0.321 105.636 -0.384
201812 0.001 105.399 0.001
201903 -0.005 106.979 -0.006
201906 -0.038 107.690 -0.045
201909 -0.001 107.611 -0.001
201912 -0.003 107.769 -0.004
202003 -0.024 107.927 -0.028
202006 -0.016 108.401 -0.019
202009 0.019 108.164 0.022
202012 0.000 108.559 0.000
202103 -0.003 110.298 -0.003
202106 -0.010 111.720 -0.011
202109 0.000 112.905 0.000
202112 -0.015 113.774 -0.017
202203 -0.010 117.646 -0.011
202206 -0.027 120.806 -0.028
202209 -0.019 120.648 -0.020
202212 0.009 120.964 0.009
202303 -0.001 122.702 -0.001
202306 0.000 124.203 0.000
202309 -0.001 125.230 -0.001
202312 0.000 125.072 0.000
202403 -0.003 126.258 -0.003

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Jolt Health  (XCNQ:JOLT) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Jolt Health Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Jolt Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Jolt Health (XCNQ:JOLT) Business Description

Industry
Traded in Other Exchanges
Address
355 Burrard Street, Suite 1780, Marine Building, Vancouver, BC, CAN, V6C 2G8
Jolt Health Inc, formerly Love Pharma Inc is a licensee of certain technologies relating to certain controlled substances and pharmaceutical-grade therapeutics. The company is investigating business opportunities in other industries however has not reached a definitive decision to pursue alternative lines of business.

Jolt Health (XCNQ:JOLT) Headlines

No Headlines